Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2002 04:00 ET | Source: atugen AG

atugen Accelerates Successful Drug Discovery Programme at ALTANA and Receives Two Milestone Payments

BERLIN, Germany, Dec. 4, 2002 (PRIMEZONE) -- atugen AG today announced that it has received two milestone payments from ALTANA Pharma AG, the international Pharmaceuticals Group of ALTANA AG...
September 17, 2002 02:14 ET | Source: atugen AG

atugen Announces New Collaboration with Schering AG, Germany

BERLIN, Germany, Sept. 17, 2002 (PRIMEZONE) -- atugen AG today announced a new collaboration with Schering AG (Frankfurt:SCHG) (NYSE:SHR) to validate a number of novel drug targets associated with...
May 14, 2002 02:44 ET | Source: atugen AG

atugen Announces Functional Genomics Collaboration with Byk Gulden

BERLIN, Germany, May 14, 2002 (PRIMEZONE) -- atugen AG today announced a three year, collaboration with Byk Gulden, the pharmaceutical group of ALTANA AG, to validate a number of novel genetic...
February 20, 2002 06:29 ET | Source: atugen AG

atugen AG Signs Technology Evaluation Agreement with Kinetek Pharmaceuticals

BERLIN, Germany, Feb. 20, 2002 (PRIMEZONE) -- atugen AG announced today the signing of a technology evaluation agreement with Kinetek Pharmaceuticals, Inc., Vancouver, Canada, a biopharmaceutical...
January 23, 2002 03:50 ET | Source: atugen AG

atugen AG Signs Target Validation Agreement with UCSF

BERLIN, Germany, Jan. 23, 2002 (PRIMEZONE) -- atugen AG, today announced the signing of an agreement with the University of California, San Francisco to utilize atugen's technology to validate the...
December 11, 2001 05:31 ET | Source: atugen AG

atugen AG Announces Target Validation Collaboration with Oxford GlycoSciences

BERLIN, Germany, Dec. 11, 2001 (PRIMEZONE) -- atugen AG announced today that it has signed a collaboration with Oxford GlycoSciences (LSE:OGS) (Nasdaq:OGSI) to validate high priority...
November 19, 2001 02:20 ET | Source: atugen AG

atugen AG Signs Evaluation Agreement with Byk Gulden (with link)

BERLIN, Germany, Nov. 19, 2001 (PRIMEZONE) -- atugen AG announced today that it has signed an evaluation agreement with the pharmaceuticals group of ALTANA, Byk Gulden (Constance), to investigate the...